Cross-Talk between TLR4 and FcγReceptorIII (CD16) Pathways

• Daniel Rittirsch,

  Affiliations Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America, Department of Traumatology, University Hospital Zurich, Zurich, Switzerland

  ⨯
• Michael A. Flierl,

  Affiliation Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America

  ⨯
• Danielle E. Day,

  Affiliation Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America

  ⨯
• Brian A. Nadeau,

  Affiliation Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America

  ⨯
• Firas S. Zetoune,

  Affiliation Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America

  ⨯
• J. Vidya Sarma,

  Affiliation Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America

  ⨯
• Clement M. Werner,

  Affiliation Department of Traumatology, University Hospital Zurich, Zurich, Switzerland

  ⨯
• Guido A. Wanner,

  Affiliation Department of Traumatology, University Hospital Zurich, Zurich, Switzerland

  ⨯
• Hans-Peter Simmen,

  Affiliation Department of Traumatology, University Hospital Zurich, Zurich, Switzerland

  ⨯
• Markus S. Huber-Lang,

  Affiliation Department of Traumatology, Hand-, Plastic-, and Reconstructive Surgery, University Hospital Ulm, Ulm, Germany

  ⨯
• Peter A. Ward

  * E-mail: pward@umich.edu

  Affiliation Department of Pathology, University of Michigan Medical School, Ann Arbor, Michigan, United States of America

  ⨯